Maccura Biotechnology Co.Ltd (SHE:300463)
China flag China · Delayed Price · Currency is CNY
12.15
+0.10 (0.83%)
Feb 4, 2026, 3:12 PM CST

SHE:300463 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
674.79671.45835.96587.35637.16612.07
Trading Asset Securities
50.260.06311.14663.72--
Cash & Short-Term Investments
724.99731.521,1471,251637.16612.07
Cash Growth
-23.69%-36.23%-8.31%96.35%4.10%37.88%
Accounts Receivable
1,2971,5891,8342,1361,9242,078
Other Receivables
19.723.327.6519.4121.6124.17
Receivables
1,3171,6131,8612,1551,9462,103
Inventory
931.05901.58907.491,0391,0761,075
Other Current Assets
439.45393.84306.33251.87195.77235.76
Total Current Assets
3,4123,6404,2224,6983,8554,025
Property, Plant & Equipment
3,6513,4072,9292,5132,0151,742
Long-Term Investments
146.85173.93172.73193.81144.1261.78
Goodwill
51.0451.04145.15145.1521.3221.32
Other Intangible Assets
359.8375.16283.25269.37194.61187.53
Long-Term Deferred Tax Assets
121.13133.78153.86161.45161.18181.9
Long-Term Deferred Charges
166.86119.6142.4113.4295.5164.23
Other Long-Term Assets
79.7275.7170.1974.4579.7781.03
Total Assets
7,9897,9768,1198,1686,5676,365
Accounts Payable
245.58316.75365.85380.89317.43402.05
Accrued Expenses
33.09136.39136.86152.61131.59149.29
Short-Term Debt
325.48255.1144.65248.08530.56921.55
Current Portion of Long-Term Debt
162.13202.42330.56139.113070
Current Portion of Leases
-8.8614.4813.213.64-
Current Income Taxes Payable
21.115.6919.3139.8423.663.48
Current Unearned Revenue
77.6972.0472.3674.417788.93
Other Current Liabilities
115.6198.7136.5435.2289.35102.61
Total Current Liabilities
980.671,1961,1211,0831,3131,798
Long-Term Debt
522.97184.12162.5285.8424.1329.7
Long-Term Leases
3.786.7912.9815.0417.15-
Long-Term Unearned Revenue
24.1323.8328.831.0728.131.79
Long-Term Deferred Tax Liabilities
74.08134179.07223.72242.65200.13
Other Long-Term Liabilities
3.977.943.83---
Total Liabilities
1,6101,5531,5081,6392,0252,360
Common Stock
604.67612.47612.47612.47556.47557.11
Additional Paid-In Capital
1,5691,7831,7811,781279.51369.15
Retained Earnings
4,1514,1794,1474,0473,6242,906
Treasury Stock
--220.24-170.18-170.18-170.18-48.44
Comprehensive Income & Other
1.2514.1814.8923.298.3412.62
Total Common Equity
6,3266,3696,3856,2934,2993,797
Minority Interest
53.2754.61226.64236.25243.16208.74
Shareholders' Equity
6,3796,4246,6116,5294,5424,005
Total Liabilities & Equity
7,9897,9768,1198,1686,5676,365
Total Debt
1,014657.29665.17701.221,1151,321
Net Cash (Debt)
-289.3774.23481.94549.84-478.29-709.18
Net Cash Growth
--84.60%-12.35%---
Net Cash Per Share
-0.470.120.790.90-0.86-1.27
Filing Date Shares Outstanding
604.67608.51606.83612.47556.47557.11
Total Common Shares Outstanding
604.67608.51606.83612.47556.47557.11
Working Capital
2,4322,4443,1023,6142,5422,227
Book Value Per Share
10.4610.4710.5210.277.726.82
Tangible Book Value
5,9155,9435,9565,8794,0833,588
Tangible Book Value Per Share
9.789.779.829.607.346.44
Buildings
-783.53783.35739.86732.5733.07
Machinery
-2,5082,3041,9931,8081,522
Construction In Progress
-1,103714.48504.0176.9729.76
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.